Epilepsy Headlines

Should EEG Periodic Discharges be Managed Similarly to Seizures?

Should EEG Periodic Discharges be Managed Similarly to Seizures?

Brain oxygenation may be compromised during periodic discharges, ultimately warranting treatment.

Seizure Reduction Likely With Surgery in Nonlesional Neocortical Epilepsy

Seizure Reduction Likely With Surgery in Nonlesional Neocortical Epilepsy

Nearly 60% of patients had achieved seizure freedom at last follow-up, 10 to 21 years after surgery.

EEG Patterns in Critically Ill Point to Greater Risk of Seizures

EEG Patterns in Critically Ill Point to Greater Risk of Seizures

Careful monitoring of EEG patterns is a useful way to stratify seizure risk in critically ill patients.

First-Line Treatment With Carbamazepine in Neonatal Epilepsy

First-Line Treatment With Carbamazepine in Neonatal Epilepsy

The results confirm the effectiveness and safety of low-dose CBZ as a first-line agent for the treatment of neonatal seizures.

Vigabatrin Plus Hormonal Therapy Superior in Infantile Spasms

Vigabatrin Plus Hormonal Therapy Superior in Infantile Spasms

Greater spasm cessation was achieved in the combination group vs those who received hormonal therapy alone.

VIDEO: Identifying Risk Factors for Post-Stroke Epilepsy

VIDEO: Identifying Risk Factors for Post-Stroke Epilepsy

Beate Diehl, MD, PhD, FRCP, discusses her research on post-stroke epilepsy.

VIDEO: Gap in Provider Knowledge Delays Diagnosis, Treatment of Infantile Spasms

VIDEO: Gap in Provider Knowledge Delays Diagnosis, Treatment of Infantile Spasms

Shaun Hussain, MD, MS, discusses a gap in health care provider knowledge that may contribute to the delay in the diagnosis and treatment of infantile spasms.

VIDEO: Elizabeth Thiele, MD, PhD Discusses Latest Cannabidiol Research

VIDEO: Elizabeth Thiele, MD, PhD Discusses Latest Cannabidiol Research

Elizabeth Thiele, MD, PhD discusses results from her research on cannabidiol in Lennox-Gastaut syndrome.

Significant Drug-Drug Interactions With Cannabidiol and Antiepileptics

Significant Drug-Drug Interactions With Cannabidiol and Antiepileptics

Clobazam had been previously identified as an AED with a significant interaction with CBD.

VIDEO — Industry Update: Justin Gover, CEO, GW Pharmaceuticals on Epidiolex Status

VIDEO — Industry Update: Justin Gover, CEO, GW Pharmaceuticals on Epidiolex Status

Justin Gover, CEO of GW Pharmaceuticals, the parent company of Greenwich Biosciences, discusses the status of the company's cannabidiol product Epidiolex on the heels of positive results from several placebo-controlled trials in epileptic syndromes.

Social Support a Significant Factor in Development of Anxiety, Depression in Epilepsy

Social Support a Significant Factor in Development of Anxiety, Depression in Epilepsy

Number of AEDs and seizure frequency also influenced depression in people with epilepsy.

Accurate Surgical Localization Using Combined Imaging Approach in Epilepsy

Accurate Surgical Localization Using Combined Imaging Approach in Epilepsy

Concordant EEG/fMRI and ESI predicted outcomes with 100% sensitivity and specificity.

Factors Predictive of Everolimus Efficacy in Tuberous Sclerosis Complex

Factors Predictive of Everolimus Efficacy in Tuberous Sclerosis Complex

Adjunctive everolimus treatment has been found to significantly reduce frequency of treatment-resistant seizures in TSC.

A Novel Risk Score for Seizures After Stroke

A Novel Risk Score for Seizures After Stroke

The triple-validated SeLECT score may help identify patients suited for antiepileptic drug trials.

Cannabidiol Reduces Seizure Frequency in Refractory Dravet Syndrome

Cannabidiol Reduces Seizure Frequency in Refractory Dravet Syndrome

Results of the phase 3, placebo-controlled trial support previous findings from an expanded-access program.

Brain Atrophy May Help Predict Surgical Outcomes in Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis

Brain Atrophy May Help Predict Surgical Outcomes in Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis

Atrophy in areas outside of the MTLE-HS network may predict poor surgical outcomes.

Major Provider Knowledge Gap Delays Diagnosis, Treatment of Infantile Spasms

Major Provider Knowledge Gap Delays Diagnosis, Treatment of Infantile Spasms

Less than 30% of patients were seen by an effective provider within 1 week of onset of infantile spasms.

Potential Reduction in Seizure Frequency With Statin Therapy

Potential Reduction in Seizure Frequency With Statin Therapy

Half of patients experienced a reduction in seizure frequency after statin initiation.

Polypharmacy Alone Worsens Quality of Life in Epilepsy

Polypharmacy Alone Worsens Quality of Life in Epilepsy

Awareness of the effects of polypharmacy on patient well-being is an important component of care.

Cannabidiol Helps Reduce Frequency of Drop Seizures in Lennox-Gastaut Syndrome

Cannabidiol Helps Reduce Frequency of Drop Seizures in Lennox-Gastaut Syndrome

Patients taking cannabidiol experienced a significant reduction in drop seizures compared with placebo.

Sign Up for Free e-newsletters